DIAGNOSTIC APPROACHES, METHODS OF TREATMENT AND MONITORING OF PATIENTS WITH ERECTILE DYSFUNCTION IN THE RUSSIAN FEDERATION: RESULTS OF A MULTICENTER RUSSIAN STUDY


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The risk of erectile dysfunction (ED) increases with age due to the occurrence of serious opportunistic diseases, particularly hypertension, heart disease, diabetes, and hypogonadism. Detection and treatment of erectile dysfunction and related diseases at an early stage can prevent their progression. As a result, disability of patients can be prevented, we can save their health and performance, and achieve budget savings. In our opinion, currently, most urologists diagnose erectile dysfunction mainly in case of complaints of the patient, without direct survey for the presence of symptoms of ED. In addition, even in case of diagnosis of ED, entire complex of surveys aimed at identifying the accompanying, sometimes very dangerous to the health of patients, diseases is often not carried out. The aim of this study was to find out what methods of diagnosis and treatment of these diseases are used in various medical centers in the Russian Federation, to trace the possible relationships and correlations between the methods of examination and treatment of patients with the above pathology, as well as center and professional experience. According to the results of questioning 783 urologist of 12 centers in Moscow, European Russia, the Urals and Western Siberia, portrait of the typical Russian urologist is made, and information about the methods of examination and treatment of patients with ED, used in various medical centers of Russia are received. Based on these data, we can conclude that further standardization of examination and treatment of patients with ED is required, in order that patients in any region of the Russian Federation could receive high-quality medical care.

全文:

受限制的访问

作者简介

A. Bernikov

SBEI HPE MSMSU n.a. A.I. Evdokimov of RMPH

Email: bemikov@mac.com
PhD, Associate Professor at the Department of Urology

LA. Reva

SBEI HPE MSMSU n.a. A.I. Evdokimov of RMPH

Department of Urology

D. Pushkar

SBEI HPE MSMSU n.a. A.I. Evdokimov of RMPH

Department of Urology

参考

  1. Chew K.K., Earle C.M.,Stuckey B.G.,Jamrozik K., Keogh E.J. Erectile dysfunction in general medicine practice: prevalence and clinical correlates. Int. 1. Impot. Res. 2000;12:41-5.
  2. Braun M., Wassmer G., Klotz T., Braun M., Wassmer G., Klotz T. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int. J. Impot. Res. 2000; 12(6):305-11.
  3. Blanker M.H., Bohnen A.M., Groeneveld F.P. Bernsen R.M., Prins A., Thomas S., Bosch J.L. Correlates for erectile and ejaculatory dysfunction in older Dutch men: a community-based study. J. Am. Geriatr. Soc. 2001; 49(4):436-42.
  4. Пушкарь Д.Ю.,Камалов А.А.,Аль-Шукри С.Х., Еркович A.A., Коган М.И., Павлов В.Н., Журавлев В.Н., Берников А.Н. Анализ результатов эпидемиологического исследования распространенности эректильной дисфункции в Российской федерации. Урология. 2012;6:5-9.
  5. Martin-Morales A., Sanchez-Cruz J.J., Saenz de Tejada /., Rodriguez-Vela L, Jimenez-CruzJ.F., Burgos-Rodriguez R. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J. Urol. 2001 ;166(2):569-74; discus. 574-75.
  6. Selvin E., Burnett A.L., Platz E.A. Prevalence and risk factors for erectile dysfunction in the US. Am.J. Med. 2007 Feb; 120(2):151 -57.
  7. Yu D.P., Liu X.H., Wei A.Y. Effect of chronic hypoxia on penile erectile function in rats. Genet Mol. Res. 2015;14(3):10482-89.
  8. Artom N., Pinna G., Musso N.R. Orlandini F., Malasoma P., Uccelli M., Artom A., Rabbia F., Pascale C., Lantieri F., Pende A. Prevalence of erectile dysfunction in a cohort of Italian hypertensive subjects. Clin. Exp. Flypertens. 2015;29:1-7.
  9. Gavornik P., Dukat A., Gaspar L., Medova D., Faktorova X., Gavornikova E. Erectile dysfunction as the first sign of systemic vascular diseases and of organovascuiar arterial ischemic diseases. Guidelines and Challenge of the Angiology section of Slovak Medical Chamber (AS SMC, 2015). Vnitr. Lek. 2015;61(7- 8):660-69.
  10. Goldstein I. The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction. Am. J. Cardiol. 2000;86(2A):41 F-45F.
  11. Pantalone K.M., Faiman C. Male hypogonadism: more than just a low testosterone. Cleve Clin. J. Med. 2012;79( 10):717-25.
  12. Tenover J.L. Male hormone replacement therapy including “andropause". Endocrinol. Metab. Clin. North Am. 1998;27(4):969-87.
  13. Biundo B. Low testosterone in older men: a discussion and review of literature on health consequences of hypogonadism in the aging male. Int. J. Pharm. Compd. 2009;13(6): 494-96.
  14. Viswanathan V., Eugster E.A. Etiology and treatment of hypogonadism in adolescents. Endocrinol. Metab. Clin. North Am. 2009;38(4):719-38.
  15. Griffing G.T., Buehler B., Speiser P.W. Hypogonadism Clinical Presentation: History, Physical, Causes. http://emedicine.medscape. com/article/922038-clinical #b 5
  16. Peer 0., Giimiis B. The treatment of late- onset hypogonadism. Turk. 1. Urol. 2014; 40(3):170-79.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2016
##common.cookie##